Condition: Pacemaker · Defibrillators, Implantable · Sponsor: Caporali Elena
Bedrest is usually prescribed for patients management after cardiac electronic device implantation (CIED) in order to prevent complication. Due to the lack of guidelines available on the timing of postoperative mobilization management, the aim of the study is to evaluate the safety of early mobilization, comparing mobilization at 4-h against day-after procedure.
This description comes directly from the study's public registry record.
Elena Caporali, MD · +41 (0)91 811 53 24 · elena.caporali@eoc.ch
Michele Villa, RN · +41 (0)91 811 50 59 · michele.villa@eoc.ch
Always discuss trial participation with your own doctor first.
| Cardiocentro Ticino Institute - EOC | Lugano, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06330675